Association of inflammation with atrial fibrillation in hyperthyroidism

Journal of Geriatric Cardiology

Volumn 9, Issue 4, 2012, Pages 344-348

  Ozaydin, Mehmet ^a   Kutlucan, Ali ^b   Turker, Yasin ^b   Koroglu, Banu ^b   Arslan, Akif ^a   Uysal, Bayram A ^a   Erdogan, Dogan ^a   Varol, Ercan ^a   Dogan, Abdullah ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b Gulkent Hospital   (Turkey)

Author keywords

Atrial fibrillation; Hyperthyroidism; Inflammation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT ATRIUM; HUMAN; HYPERTHYROIDISM; INFLAMMATION; LIOTHYRONINE BLOOD LEVEL; MALE; SINUS RHYTHM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 84874089842     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2012.06251     Document Type: Article

References (34)

1. Bielecka-Dabrowa A., Mikhailidis DP, Rysz J, et al The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Research 2009; 2: 4.
2. Staffurt JS, Gibberd JS, Tang FS Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 1977; 2: 688-690.
3. Selcuk MT, Selcuk H, Maden O., et al Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis. J Heart Valve Dis 2007; 16: 468-474.
4. Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004; 62: 105-111.
5. Chung MK, Martin DO, Sprecher D, et al C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891.
6. Frustaci A, Chimenti C, Bellocci F., et al Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-1184.
7. Ucer E, Gungor B, Erdinler I.C., et al High sensitivity CRP levels predict atrial tachyarrhythmias in rheumatic mitral stenosis. Ann Noninvasive Electrocardiol 2008; 13: 31-38.
8. Chiu-Braga Y.Y., Hayashi SY, Schafranski M, et al Further evidence of inflammation in chronic rheumatic valve disease (CRVD): High levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein. Int J Cardiol 2006; 109: 275-276.
9. Golbasi Z, Ucar O, Keles T., et al Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease evidence of ongoing inflammation. Eur J Heart Fail 2002; 4: 593-595.
10. Yetkin E, Erbay AR, Ileri M, et al Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 2001; 88: 1209-1211.
11. Ozaydin M, Turker Y, Erdogan D., et al The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome. Int J Cardiol 2010; 141: 147-150.
12. Ortmann C, Pfeiffer H, Du Chesne A, et al Inflammation of the cardiac conduction system in a case of hyperthyroidism. Int J Legal Med 1999; 112: 271-274.
13. Pearce EN, Bogazzi F, Martino E., et al The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid 2003; 13: 643-648.
14. Christ-Crain M., Meier C, Guglielmetti M., et al Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a doubleblind, placebo-controlled trial. Atherosclerosis 2003; 166: 379-386.
15. Senturk T, Kozaci LD, Kok F, et al Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med 2003; 26: 58-63.
16. Siddiqi A, Monson JP, Wood D.F., et al Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab 1999; 84: 435-439.
17. Devereux RB, Alonso DR, Lutas E.M., et al Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
18. Gammage MD, Parle JV, Holder R.L., et al Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007; 167: 928-934.
19. Heeringa J, Hoogendoorn EH, van der Deure WM, et al. High-normal thyroid function and risk of atrial fibrillation: The rotterdam study. Arch Intern Med 2008; 168: 2219-2224.
20. Iwasaki T, Naka M, Hiramatsu K., et al Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease. Cardiology 1989; 76: 10-17.
21. Sawin CT, Geller A, Wolf P.A., et al Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-1252.
22. Wang J, Liu L, Feng J., et al Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs. Am J Physiol 1996; 271: H148-H158.
23. Olsson SB. Atrial fibrillation-where do we stand today? J Intern Med 2001; 250: 19-28.
24. Chen YC, Chen SA, Chen YJ, et al. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol 2002; 39: 366-372.
25. Sun ZQ, Ojamaa K, Nakamura T.Y., et al Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol 2001; 33: 811-824.
26. Wustmann K, Kucera JP, Zanchi A, et al Activation of Electrical Triggers of Atrial Fibrillation in Hyperthyroidism. J Clin Endocrinol Metab 2008; 93: 2104-2108.
27. Biondi B, Fazio S, Coltorti F., et al Clinical case seminar: Reentrant atrioventricular nodal tachycardia induced by levothyroxine. J Clin Endocrinol Metab 1998; 83: 2643-2645.
28. Tribulova N, Varon D, Polak-Charon S, et al Aged heart as a model for prolonged atrial fibrilloflutter. Exp Clin Cardiol 1999; 4: 64-72.
29. Kostin S, Klein G, Szalay Z., et al Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002; 54: 361-379.
30. Spach MS, Heidlage JF The stochastic nature of cardiac propagation at a microscopic level. An electrical description of myocardial architecture and its application to conduction, Circ Res 1995; 76: 366-380.
31. Komiya N, Isomoto S, Nakao K., et al Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. Clin Endocrinol 2002; 56: 39-44.
32. Freedberg AS, Papp JG, Vaughan-Williams EM. The effect of altered thyroid state on atrial intracellular potentials. J Physiol 1970; 207: 357-369.
33. Fazio S, Palmieri EA, Lombardi G, et al Effects of Thyroid Hormone on the Cardiovascular System. Recent Progr Horm Res 2004; 59: 31-50.
34. Sgarbi JA, Villaca FG, Garbeline B, et al The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metab 2003; 88: 1672-1677.